ATOSSA THERAPEUTICS, INC. Annual Depreciation in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Atossa Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2011 to 2023.
  • Atossa Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $5K, a 66.7% increase year-over-year.
  • Atossa Therapeutics, Inc. annual Depreciation for 2023 was $23K, a 188% increase from 2022.
  • Atossa Therapeutics, Inc. annual Depreciation for 2022 was $8K, a 20% decline from 2021.
  • Atossa Therapeutics, Inc. annual Depreciation for 2021 was $10K, a 47.4% decline from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $23K +$15K +188% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 $8K -$2K -20% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 $10K -$9K -47.4% Jan 1, 2021 Dec 31, 2021 10-K 2022-02-28
2020 $19K -$3K -13.6% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-28
2019 $22K +$8K +57.1% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 $14K -$12K -46.1% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-26
2017 $26K -$99.7K -79.3% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-28
2016 $126K +$52.6K +71.9% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-08
2015 $73.1K -$71.8K -49.6% Jan 1, 2015 Dec 31, 2015 10-K/A 2017-03-21
2014 $145K +$61.9K +74.6% Jan 1, 2014 Dec 31, 2014 10-K 2015-03-30
2013 $83K +$57.9K +231% Jan 1, 2013 Dec 31, 2013 10-K 2015-03-30
2012 $25.1K +$21.2K +540% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-27
2011 $3.92K Jan 1, 2011 Dec 31, 2011 10-K 2013-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.